Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Lefer

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Pharmacology|September 23, 2008
Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetesD J Lefer
Annual Review of Pharmacology and Toxicology|June 3, 2000
Pharmacology of selectin inhibitors in ischemia/reperfusion statesD J Lefer
New Horizons (Baltimore, Md.)|February 1, 1995
Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusionD J Lefer
Circulation Research|June 12, 1999
Monocyte rolling in early atherogenesis: vital role in lesion developmentD J Lefer, D N Granger
The American Journal of Physiology|March 10, 1999
Nitric oxide. II. Nitric oxide protects in intestinal inflammationA M Lefer, D J Lefer
The American Journal of Medicine|September 21, 2000
Oxidative stress and cardiac diseaseD J Lefer, D N Granger
Basic Research in Cardiology|January 1, 1991
Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicalsA M Lefer, D J Lefer
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1984
Coronary vascular actions of the converting enzyme inhibitor, enalaprilD J Lefer, A M Lefer
Basic Research in Cardiology|February 24, 2001
Using gene-targeted mice to investigate the pathophysiology of myocardial reperfusion injuryS P Jones, D J Lefer
Cardiovascular Research|December 1, 1993
Nitric oxide homeostasis control as therapy for cardiovascular diseasesD J Lefer, A M Lefer
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Pharmacology|September 23, 2008
Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetesD J Lefer
Annual Review of Pharmacology and Toxicology|June 3, 2000
Pharmacology of selectin inhibitors in ischemia/reperfusion statesD J Lefer
New Horizons (Baltimore, Md.)|February 1, 1995
Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusionD J Lefer
Circulation Research|June 12, 1999
Monocyte rolling in early atherogenesis: vital role in lesion developmentD J Lefer, D N Granger
The American Journal of Physiology|March 10, 1999
Nitric oxide. II. Nitric oxide protects in intestinal inflammationA M Lefer, D J Lefer
The American Journal of Medicine|September 21, 2000
Oxidative stress and cardiac diseaseD J Lefer, D N Granger
Basic Research in Cardiology|January 1, 1991
Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicalsA M Lefer, D J Lefer
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1984
Coronary vascular actions of the converting enzyme inhibitor, enalaprilD J Lefer, A M Lefer
Basic Research in Cardiology|February 24, 2001
Using gene-targeted mice to investigate the pathophysiology of myocardial reperfusion injuryS P Jones, D J Lefer
Cardiovascular Research|December 1, 1993
Nitric oxide homeostasis control as therapy for cardiovascular diseasesD J Lefer, A M Lefer
Pageof 10